MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$5,533K
EPS
-$0.07
Unit: Thousand (K) dollars

Income Statement
2025-12-31
General and administrative
1,356
Transaction expenses
3,955
Total operating expenses
5,311
Operating loss
-5,311
Interest and dividend income
1,921
(loss) income before income tax expense
-3,390
Income tax expense
19
Net (loss) income
-3,409
Dividends on series c preferred stock
2,124
Net loss available to common shareholders
-5,533
Basic EPS
-0.07
Diluted EPS
-0.07
Basic Average Shares
74,215,000
Diluted Average Shares
74,215,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss availableto common...-$5,533K Net (loss) income-$3,409K Dividends on series cpreferred stock$2,124K (loss) income beforeincome tax expense-$3,390K Income tax expense$19K Interest and dividendincome$1,921K Operating loss-$5,311K Total operatingexpenses$5,311K Transaction expenses$3,955K General andadministrative$1,356K

ENZON PHARMACEUTICALS, INC. (ENZN)

ENZON PHARMACEUTICALS, INC. (ENZN)